Nikola Charles Teslovich, MD
Urology · Renton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Valley Medical Group-Renton · 419 clinicians in this group
Hospitals listed: Valley Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Teslovich’s office at (425) 656-5365 to ask if they take your plan before you enroll.
California Medical Board record
Licence G11111 · Cancelled
Licence status: Cancelled · since 1965 · Jefferson Medical College of Thomas Jefferson University.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.70003219Physician And Surgeon License · since 2025 · expires 2028-09-14Matched by name, not licence number; check the name before relying on it.ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Valley Medical CenterRenton, WAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of UW Medicine, which runs 4 hospitalsPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.69 (1.38 to 1.99), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 3.51 (2.89 to 4.13) · 5,445 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.4 (10.8 to 19) · 208 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.441, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.513, Oct 2024 – Sep 2025
See every measure and the patient survey for Valley Medical Center
Behind the star rating — Deaths: 1 better, 4 the same, 2 worse of 7 measures. Safety: 1 better, 4 the same, 1 worse of 6 measures. Readmissions: 2 better, 5 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.69 (1.38 to 1.99) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 3.51 (2.89 to 4.13) · 5,445 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.4 (10.8 to 19) · 208 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.441 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.513 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.75) · 1,237 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 175.11 (128.65 to 221.56) · 92 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 107 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 16.2 · 511 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.4 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 506 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,498 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.34) · 6,246 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.13 to 0.51) · 6,227 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.2 (1.2 to 5.2) · 1,469 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.9 (0.27 to 3.53) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (1.17 to 4.12) · 1,452 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.56 (0 to 13.24) · 571 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.55 (0 to 7.13) · 497 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 312 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 30 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.003 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.869 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 199 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -28.9 · 102 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 13.1 · 386 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 638 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.3 (2.9 to 6.3) · 208 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 25 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 279 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.9 to 15.9) · 2,650 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.3) · 760 cases | No different | Jan 2024 – Dec 2024 |
What patients said (904 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 59% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Prostate resection | 1-10 | None |
Drugs they prescribed that Part D paid
$34,259
Pharmacies billed $34,259 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 23% of their Part D prescriptions (43 of 191) in 2024. A higher opioid share than 9 in 10 peers; the typical urology clinician is at 2%.
147 generic and fewer than 11 brand-name prescriptions · $34,259 in drug cost · 35 antibiotic prescriptions to 33 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 29 | $29,410 | $1,014 |
| Tamsulosin | 27 | $179 | $7 |
| Finasteride | 11 | $145 | $13 |
| Oxycodone | 20 | $59 | $3 |
| Ibuprofen | 16 | $55 | $3 |
See all 6 drugs
| Myrbetriq | 29 | $29,410 | $1,014 |
| Tamsulosin | 27 | $179 | $7 |
| Finasteride | 11 | $145 | $13 |
| Oxycodone | 20 | $59 | $3 |
| Ibuprofen | 16 | $55 | $3 |
| Tramadol | 20 | $23 | $1 |
Year by year
| 2024 | 191 | 105 | 23% (43) | None | $34,259 |
| 2023 | 81 | 48 | 28% (23) | None | $6,641 |
| 2022 | 20 | None | None | None | $476 |
| 2021 | 96 | 62 | 19% (18) | None | $3,100 |
| 2020 | 39 | 27 | None | None | $955 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Oxycodone | 20 | $61 | $3 |
2021: 3 drugs
| Tamsulosin | 18 | $258 | $14 |
| Cephalexin | 13 | $99 | $8 |
| Oxycodone | 12 | $34 | $3 |
2020: 1 drug
| Tamsulosin | 13 | $132 | $10 |
Money from drug and device companies
$188 in 2024
| 2024 | 1 | 3 | None | $188 |
| 2023 | 1 | 2 | None | $157 |
| 2022 | 1 | 1 | None | $125 |
| 2021 | 2 | 2 | None | $83 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Ams 700 | $188 | 3 payments
|
See all 3 published payments
| Boston Scientific | Meals · 2024-09-13 | Solyx Sis System | $7 |
| Boston Scientific | Meals · 2024-09-13 | Solyx Sis System | $41 |
| Boston Scientific | Meals · 2024-06-15 | Ams 700 | $141 |
See earlier years (2023, 2022, 2021)
2023: $157
| Boston Scientific | None | $157 | 2 payments
|
2022: $125
| Dornier MedTech America | Dornier Medtech | $125 | 1 payment
|
2021: $83
| Boston Scientific | General Kidney Stone Disease | $46 | 1 payment
|
| Lumenis | Lumenis Pulse 120h | $37 | 1 payment
|
Professional record
- NPI
- 1619439221
- Licence
- CA 11111California G11111: CancelledWashington MD.MD.70003219: Active
- Trained
- Stanford University School of Medicine, 2019
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 4033 Talbot Rd S Ste 500, Renton, WA, 98055
- NPI first listed
- 2019-04-02
- NPI last updated
- 2026-02-06
- NPI record certified
- 2026-02-06
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.